ScienceDaily highlighted new research from scientists at the Lewis Katz School of Medicine at Temple University on LIN28 – a protein normally expressed in the developing heart. To augment heart repair after ischemic injury, researchers have turned to stem cell-based therapies, which replace dead heart tissue with new, functional tissue. In most cases, however, fewer than 1 percent of stem cells survive transplantation into the heart. Now, Katz School of Medicine scientists show that, in mice, this obstacle can be overcome through the reintroduction of LIN28 into stem cells derived from adult heart tissue. The new findings were published online in the journal Redox Biology. Mohsin Khan, PhD, Assistant Professor of Cardiovascular Sciences at the Cardiovascular Research Center at the Katz School of Medicine, is the senior investigator on the new study.